A. Jackman

Publications199
h-index42
Citations5,835
Highly Influential Citations160
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Calvert
  • 178 Publications • 4,500 Citations
  • R. Kimbell
  • 42 Publications • 1,370 Citations
  • F. T. Boyle
  • 76 Publications • 1,989 Citations
  • L. Sherman
  • 52 Publications • 1,640 Citations
  • Publications
  • Influence
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
TLDR
This folate antagonist structure-activity relationship can be of value for predicting drug sensitivity and resistance of tumor cells or drug-related toxicity to normal cells and for the rational design and development of novel antifolates.
HPV16 E6 augments Wnt signaling in an E6AP-dependent manner.
Folate-based thymidylate synthase inhibitors as anticancer drugs.
  • A. Jackman, A. Calvert
  • Biology, Chemistry
    Annals of oncology : official journal of the…
  • 1 November 1995
TLDR
A portfolio of novel compounds comprehensively addresses the potential of thymidylate synthase as a target for cancer chemotherapy.
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
TLDR
Resistance to thymidylate stress in bcl-2-expressing cells therefore occurred by a mechanism different from those which classically define resistance to this type of cytotoxic drug.
HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer.
BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
TLDR
The data suggest that BGC 945 selectively inhibits thymidylate synthase in alpha-FR-overexpressing tumors and should cause minimal toxicity to humans at therapeutic doses.
Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression
TLDR
Evidence including region specific microarray analysis indicated that overexpression of several genes from a region may be required for detection by CESH, which is consistent with clusters of functionally related genes and mechanisms that affect the expression of a number of genes at a particular genomic location.
ICI D1694, an inhibitor of thymidylate synthase for clinical study.
The TS inhibitor, ICI D1694, is a highly potent inhibitor of tumour growth in vitro and in vivo. Uptake via the RFC and rapid metabolism to polyglutamate forms appear to be responsible for potency.…
...
1
2
3
4
5
...